Product Information

PRAVASTATIN SODIUM 20 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0580 per EA under NDC 82009000610. Its NADAC has been published 237 times since Mar 23, 2022.

FDA first approved this application on Oct 23, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the PRAVASTATIN SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PRAVASTATIN SODIUM 20 MG TAB

PRAVASTATIN SODIUM
$0.0580per EA
High Outlier

Strength

20 mg/1

NDC

82009000610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Active Ingredients

PRAVASTATIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA076341

FDA Approved

10/23/2006

TE Code

AB

On Market Since

12/3/2021

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PRAVASTATIN SODIUM 20 MG TAB has been published 237 times since Mar 23, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0580 per EA
All-time high$0.0715 (Sep 10, 2025)
All-time low$0.0505 (Nov 20, 2024)
52-week high$0.0703
52-week low$0.0580
Median price$0.0624
Average price$0.0624
Largest weekly change+24.2% (Jun 19, 2024)
Weeks tracked237
Tracking sinceMar 23, 2022

Price History

1W

0.0%

1M

-6.5%

3M

-6.8%

6M

-7.1%

1Y

-17.5%

3Y

-15.4%

5Y

N/A

All

+0.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRAVASTATIN SODIUM 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for PRAVASTATIN SODIUM 20 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0580 per EA (NDC 82009000610), effective Sep 30, 2026.

How has the price of PRAVASTATIN SODIUM 20 MG TAB changed over time?

Over the history we have for it, the NADAC for PRAVASTATIN SODIUM 20 MG TAB has held within roughly two percent of its current level. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for PRAVASTATIN SODIUM 20 MG TAB?

Since Mar 23, 2022, the NADAC for PRAVASTATIN SODIUM 20 MG TAB has ranged from a low of $0.0505 (Nov 20, 2024) to a high of $0.0715 (Sep 10, 2025), with a median of $0.0624 per EA.

Are there cheaper alternatives to PRAVASTATIN SODIUM 20 MG TAB?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAVASTATIN SODIUM 20 MG TAB, is $0.0519 per EA — about 10% below PRAVASTATIN SODIUM 20 MG TAB.

Who manufactures PRAVASTATIN SODIUM 20 MG TAB?

PRAVASTATIN SODIUM 20 MG TAB (NDC 82009000610) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.